Intermittent low dose irradiation enhances the effectiveness of radio-therapy for human breast adenocarcinoma cell line MDA–MB–231
(ندگان)پدیدآور
Danyaei, AmirMansoury Asl, HalimeTeimoori, AliTahmasbi, MohammadjavadKhanbabaei, Hashem
نوع مدرک
TextConference Proceedings
زبان مدرک
Englishچکیده
Introduction:
Hormesis and adaptive responses are two important biological effects of low-dose ionizing radiation (LDIR) in organism and mammalian cell lines. Notably, LDIR generates distinct
biological effects in cancer cells from normal cells, e.g., it may affect the growth of cancer cells via the activation of certain cell signaling pathway, which does not exist in normal cells. Therefore, LDIR is considered as a promising assistant method of clinical cancer therapy.
Materials and Methods:
In order to investigate the intermittent LDIR effect on breast cancer, MDA–MB–231 cells were divided into four experimental groups. Group A, cells were irradiated in 10 fractions
with a dose of 30 mGy at each one. The time interval between two irradiations was 24h.
Group B, were cultured simultaneously for the same10 days and received a dose of 300 mGy
and subsequently a high dose of 2 Gy after 24h. Group C, accepted a single high dose of 2 Gy.
Group D was mock irradiation group as control. We examined cell proliferation activity using
MTT assay and PI-Annexin V kit to assay cell apoptosis after 24 hours of last irradiation dose
(2Gy). Also we used RT-PCR to examine the cell cycle arrest and apoptosis pathway. For this
purpose we examined p21 and cespase3 genes in this study.
Results:
The intermittent LDIR increased cell apoptosis up to 32.55% and in other groups, apoptosis
were 30.14%, 25.49% and 8.37% in single LDIR, HDIR and control group respectively. The
apoptosis percentages were markedly higher than in the intermittent LDIR groups (PConclusion:
Intermittent LDIR followed by HDIR are a novel strategy to improve radiotherapy efficiency
and could be combined with other therapeutic modalities for cancer treatments. Low dose
has a different mechanism for killing cancer cells, therefore, it has no killing effect
on normal cells.
کلید واژگان
low dose irradiationBreast Adenocarcinoma
Radiotherapy
cell signaling
شماره نشریه
12تاریخ نشر
2018-12-011397-09-10
ناشر
Mashhad University of Medical Sciencesسازمان پدید آورنده
Department of Medical Physics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Medical Physics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Medical Physics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Medical Physics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran



